Related references
Note: Only part of the references are listed.Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
Ranjit Manchanda et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
Ranjit Manchanda et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Impact of subsidies on cancer genetic testing uptake in Singapore
Shao-Tzu Li et al.
JOURNAL OF MEDICAL GENETICS (2017)
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Joanne Kotsopoulos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
NCCN Guidelines® Insights Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 Featured Updates to the NCCN Guidelines
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Joanne Kotsopoulos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Pathology update to the Manchester Scoring System based on testing in over 4000 families
D. Gareth Evans et al.
JOURNAL OF MEDICAL GENETICS (2017)
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
Fergus J. Couch et al.
JAMA ONCOLOGY (2017)
A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes
Saundra S. Buys et al.
CANCER (2017)
Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis
S. G. Smith et al.
ANNALS OF ONCOLOGY (2016)
Current Status of the Management of Hereditary Breast and Ovarian Cancer in Asia: First Report by the Asian BRCA Consortium
Seigo Nakamura et al.
PUBLIC HEALTH GENOMICS (2016)
When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer
B. Meiser et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
Susan M. Domchek et al.
GYNECOLOGIC ONCOLOGY (2016)
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
Ella R. Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
Bella Kaufman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and/or Ovarian Cancer
Daniel Trujillano et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
Jack Cuzick et al.
LANCET ONCOLOGY (2015)
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Douglas F. Easton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
MRI breast screening in high-risk women: cancer detection and survival analysis
Evans D. Gareth et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
T. Byrski et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02)
D. G. Evans et al.
FAMILIAL CANCER (2014)
Quality of Cancer Family History and Referral for Genetic Counseling and Testing Among Oncology Practices: A Pilot Test of Quality Measures As Part of the American Society of Clinical Oncology Quality Oncology Practice Initiative
Marie E. Wood et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
Jack Cuzick et al.
LANCET (2014)
Breast Reconstruction following Nipple- Sparing Mastectomy: Predictors of Complications, Reconstruction Outcomes, and 5-Year Trends
Amy S. Colwell et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
The 'Other' Breast Cancer Genes
Sam Kean
SCIENCE (2014)
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
Kelly Metcalfe et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Genetic services and testing in South Africa
Jennifer G. R. Kromberg et al.
JOURNAL OF COMMUNITY GENETICS (2013)
Improved sub-areolar breast tissue removal in nipple-sparing mastectomy using hydrodissection
Secondo Folli et al.
BREAST (2012)
Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: Further evidence of benefit
Andrew Maurice et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study
Sook-Yee Yoon et al.
FAMILIAL CANCER (2011)
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer
Victor G. Vogel et al.
CANCER PREVENTION RESEARCH (2010)
Treatment-focused DNA testing for newly diagnosed breast cancer patients: some implications for clinical practice
E. A. Lobb et al.
CLINICAL GENETICS (2010)
BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications
Allison W. Kurian
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2010)
Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study
LANCET ONCOLOGY (2010)
The role of BRCA mutation testing in determining breast cancer therapy
Alison H. Trainer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
A. C. Antoniou et al.
BRITISH JOURNAL OF CANCER (2008)
The changing global patterns of female breast cancer incidence and mortality
F Bray et al.
BREAST CANCER RESEARCH (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Share Paper
